Coherus Oncology (CHRS) EBIT (QoQ) (2013 - 2026)
Coherus Oncology (CHRS) EBIT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Coherus Oncology | 222.16 Mn | 116.86 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.57% |
| Mar 31, 2026 | 21.21% |
| Dec 31, 2025 | -3.49% |
| Sep 30, 2025 | 2.53% |
| Jun 30, 2025 | -0.11% |
| Mar 31, 2025 | -0.11% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | -18.25% |
| Jun 30, 2024 | 41.54% |
| Mar 31, 2024 | 1.62% |
| Dec 31, 2023 | -115.29% |
| Sep 30, 2023 | 7.34% |
| Jun 30, 2023 | 49.01% |
| Mar 31, 2023 | -31.56% |
| Dec 31, 2022 | 35.99% |
| Sep 30, 2022 | -82.78% |
| Jun 30, 2022 | 45.61% |
| Mar 31, 2022 | -104.63% |
| Dec 31, 2021 | -20.62% |
| Sep 30, 2021 | -35.69% |